Archives

EQT Real Estate acquires a five-building logistics portfolio across three locations in Southern France

Picture

  • Acquisition of five logistics assets totaling approximately 148,000 square meters
  • Let to nine tenants, this highly reversionary portfolio has a weighted average remaining lease term to break of less than two years
  • With this transaction, EQT Real Estate will meaningfully increase its exposure to the core Southeast and Southwest France logistics markets

EQT Real Estate is pleased to announce that EQT Exeter Logistics Value Fund IV has acquired a best-in-class logistics portfolio of five warehouses.

The portfolio of big-box assets totals approximately 148,000 square meters and are located in the key Southern France submarkets of Avignon and Toulouse. The warehouses’ respective locations offer proximate access to core population centres via key motorways, including the A20 and the A7 which provide connectivity to Marseille and Lyon.

The properties feature Grade A technical specifications, including eaves heights averaging over ten meters, as well as ample loading and maneuvering features. The portfolio benefits from a strong, global diversified tenant base and is well-suited to meet the growing needs of today’s modern logistics users.

This acquisition strengthens EQT Real Estate’s exposure to core Southern France submarkets, which are structurally undersupplied and continue to experience resilient demand. These are highly desirable occupier markets benefiting from the excellent connectivity which supports supply chains along the Atlantic and Mediterranean coasts.

John Toukatly, Partner, Chief Investment Officer, European Logistics at EQT Real Estate, said: “We are excited to add these top-tier logistics properties to our portfolio. Situated in supply-constrained markets, these assets are highly attractive to a wide range of major big-box tenants and are well aligned with EQT Real Estate’s strategy of acquiring modern, high-potential logistics properties in underserved areas across Europe. With our operational and asset management capabilities, we intend to further enhance the value of this high-quality portfolio.”

EQT Real Estate was advised by PwC (financial and tax), Gide and GMH Notaires (legal and notarial), CBRE (commercial), Tauw (environmental), AMF (ICPE and PM) and Gleeds (technical and ESG).

Contact
EQT Press Office, press@eqtpartners.com

Downloads

About EQT Real Estate
EQT is a purpose-driven global investment organization with EUR 273 billion in total assets under management (EUR 142 billion in fee-generating assets under management) as of 31 March 2025, divided into two business segments: Private Capital and Real Assets. EQT supports its global portfolio companies and assets in achieving sustainable growth, operational excellence, and market leadership. Within EQT’s Real Assets segment, EQT Real Estate acquires, develops, leases, and manages logistics and residential properties in the Americas, Europe, and Asia. EQT Real Estate owns and operates over 2,500 properties and 540 million square feet, with over 440 experienced professionals across 50 locations globally.

More info: www.eqtgroup.com
Follow EQT Real Estate on LinkedIn

Categories: News

Tags:

CapMan appoints James O’Neill as Managing Director to its Fund Investor Relations team to serve its growing and internationalising investor base

Capman

CapMan appoints James O’Neill as Managing Director to its Fund Investor Relations team to serve its growing and internationalising investor base

CapMan is pleased to announce the appointment of James O’Neill as Managing Director, Real Estate to its Fund Investor Relations team. This strategic recruitment underscores CapMan’s commitment to expanding its investor relations and fundraising capabilities and driving growth in the international private real asset sector.

CapMan Real Estate has over the past years demonstrated remarkable growth in its Nordic real estate product offerings, ranging today from value-add funds to open-ended income-oriented funds investing in residential, hotel, and public sector real estate. Since 2013, its Nordic strategies have successfully raised over EUR 3.6 billion from a global institutional investor base. This achievement highlights CapMan Real Estate’s ability to attract international capital and deliver exceptional value to its investors.

James O’Neill brings over 20 years of experience in international real asset fundraising and business development as he joins CapMan. He has previously held key positions as Executive Director and Head of Equity Placement UK at CBRE Capital Advisors and as Head of International Distribution at Legal & General Investment Management, Real Assets.

“We are thrilled to welcome James O’Neill to our team at a time, when real assets already account for three quarters of CapMan’s EUR 6.4 billion asset under management,” says Mari Simula, Head of Fund Investor Relations at CapMan.

“O’Neill’s expertise, global institutional investor network, and deep understanding of private market dynamics will be instrumental in advancing our fundraising initiatives and achieving our strategic objectives,” adds Mika Matikainen, Managing Partner of CapMan Real Estate.

In his new role, O’Neill will be responsible for developing and executing fundraising strategies, identifying potential investors, and managing investor relations primarily for CapMan’s real estate funds.

“I am excited to join CapMan and contribute to its successful and growing real assets product offering,” says O’Neill.

“CapMan has a unique position across private markets in the Nordics, and I look forward to working with the team to continue developing our investment strategies and deepening relationships with our investors,” he continues.

This appointment supports CapMan’s objective to increase its assets under management to EUR 10 billion during the ongoing strategy period.

For more information, please contact:

Mari Simula, Head of Fund Investor Relations, CapMan, mari.simula@capman.com

Mika Matikainen, Managing Partner, CapMan Real Estate, mika.matikainen@capman.com

About CapMan

CapMan is a leading Nordic private asset expert with an active approach to value creation and €6.4 billion in assets under management. As one of the private equity pioneers in the Nordics we have developed hundreds of companies and assets creating significant value for over three decades. Our objective is to provide attractive returns and innovative solutions to investors by enabling change across our portfolio companies. An example of this is greenhouse gas reduction targets that we have set under the Science Based Targets initiative in line with the 1.5°C scenario and our commitment to net-zero GHG emissions by 2040. We have a broad presence in the unlisted market through our local and specialised teams. Our investment strategies cover real estate and infrastructure assets, natural capital and minority and majority investments in portfolio companies. We also provide wealth management solutions. Altogether, CapMan employs around 200 professionals in Helsinki, Jyväskylä, Stockholm, Copenhagen, Oslo, London and Luxembourg. We are listed on Nasdaq Helsinki since 2001. www.capman.com

Categories: People

AURELIUS appoints Shawn der Kinderen as General Counsel M&A

Aurelius Capital

London/Amsterdam, June 2, 2025 – AURELIUS has appointed Shawn der Kinderen as General Counsel M&A, based at AURELIUS’ Amsterdam office. Shawn joins us from Landcent Europe, where he was Chief Legal Officer, and is a former Partner at Freshfields. The appointment underscores AURELIUS’ continued international growth and increasing investment scale.

Shawn brings over 25 years of experience in the legal profession, including 16 years as a Corporate/M&A Partner at Freshfields, one of the world’s leading international law firms. During his tenure, he held several senior leadership positions, including Head of the Amsterdam Corporate, M&A and Private Equity team and Co-Head of the Africa Business Group. Since leaving Freshfields in 2022, Shawn has served in a range of board advisory, director, and consultancy roles. Most recently, he supported Landcent Europe’s mission to fight diseases of poverty across Africa.

“AURELIUS has a unique set-up within the private equity industry. Its global investment expertise, combined with its operational approach, enables it to identify and capture deal opportunities that others cannot pursue. I’m excited to join the team and contribute to AURELIUS’ continued success,” says Shawn der Kinderen. “AURELIUS is growing and so is the complexity and size of our investments. We are delighted to add Shawn to our team. He is an industry-renowned specialist with a track record of successfully handling complex private equity deals. We are convinced he will further boost our dealmaking capabilities”, says Donatus Albrecht, Partner at AURELIUS Investment Advisory.

Categories: People

bluebird bio Announces Completion of Acquisition by Carlyle and SK Capital

Carlyle

New management, led by David Meek, is committed to rapidly scaling access to lifechanging gene therapies

Significant capital commitment from Carlyle and SK Capital will enable bluebird to grow and accelerate patient access

bluebird will focus on expanding manufacturing capacity and improving the treatment experience for patients and providers

SOMERVILLE, Mass. — June 2, 2025 — bluebird bio (NASDAQ: BLUE) (“bluebird”), a pioneer in gene therapies for severe genetic diseases, today announced the completion of its sale to funds managed by global investment firms Carlyle (NASDAQ: CG) and SK Capital Partners, LP (“SK Capital”). With the closing of the transaction, bluebird’s common stock has ceased trading and will no longer be publicly listed. Carlyle and SK Capital have provided significant primary capital to support and scale bluebird’s commercial delivery of gene therapies for patients with sickle cell disease, β-thalassemia, and cerebral adrenoleukodystrophy.

David Meek, who became Chief Executive Officer of bluebird at close, said, “Today marks the beginning of a new era for bluebird as its go-forward financial backing and leadership team will better enable all stakeholders to realize the full potential of our revolutionary therapies. Historically, bluebird has excelled as a scientific innovator and should be very proud of the many achievements it has delivered to patients. Our vision is to further that legacy of scientific excellence while improving the commercial execution of our approved products to rapidly expand access to lifechanging gene therapies.”

“We are excited to back bluebird in partnership with SK Capital. We believe providing bluebird the necessary funding along with the new leadership team will help bluebird realize its full potential,” said Joe Bress, Carlyle Partner and Global Co-Head of Healthcare. Bali Muralidhar, Co-Managing Partner and Chief Investment Officer & COO of Abingworth, Carlyle’s life sciences investment franchise, added, “There is an incredible opportunity to bring bluebird’s groundbreaking therapies to more patients in need, and we look forward to advancing bluebird in its mission.”

“SK Capital looks forward to partnering with David and his team as well as Carlyle to scale bluebird’s pioneering gene therapies that can make a lifechanging difference for patients around the world,” said Aaron Davenport, Managing Director at SK Capital, adding, “We believe our deep collective experience in manufacturing and commercializing therapies can help drive the next chapter of bluebird’s growth.”

Incoming Team Bolsters Commercial Gene Therapy Experience 

The company’s momentum is reinforced by a deeply experienced management team, led by CEO David Meek. David brings more than 30 years of leadership in life sciences, including as CEO of Mirati Therapeutics and Ipsen. David is joined by Tom Klima as Chief Commercial & Operating Officer, Debasish Roychowdhury, M.D., as Chief Medical Officer, Wendy DiCicco as Chief Financial Officer, and Ellen Forest as Chief People Officer. Additional details are available at https://www.bluebirdbio.com/about-us/leadership.

From Scientific Breakthroughs to Delivery at Scale

With the transaction now closed, bluebird is prioritizing expanding its manufacturing infrastructure, streamlining the patient journey, supporting treatment centers, and strengthening its payer partnerships. The acquisition provides the strategic and financial backing needed to meet rising demand and drive commercial and operational excellence across the organization.

“bluebird has demonstrated what’s possible through effective gene therapy,” David added. “Now we will build the ecosystem to ensure every patient who needs these therapies can access them.”

About bluebird bio

bluebird bio is a commercial-stage biotherapeutics company focused on developing and delivering gene therapies for severe genetic diseases. With more than a decade of scientific leadership in gene therapy and three FDA-approved therapies for sickle cell disease, β-thalassemia, and cerebral adrenoleukodystrophy, the company is committed to ensuring access, reliability, and patient-centered care. bluebird is headquartered in Somerville, Massachusetts.

About Carlyle

Carlyle (NASDAQ: CG) is a global investment firm with deep industry expertise that deploys private capital across its business and conducts its operations through three business segments: Global Private Equity, Global Credit and Carlyle AlpInvest. With $453 billion of assets under management as of March 31, 2025, Carlyle’s purpose is to invest wisely and create value on behalf of its investors, portfolio companies, and the communities in which we live and invest. Carlyle employs more than 2,300 people in 29 offices across four continents. Further information is available at www.carlyle.com. Follow Carlyle on X @OneCarlyle and LinkedIn at The Carlyle Group.

About SK Capital

SK Capital is a transformational private investment firm with a disciplined focus on the life sciences, specialty materials, and ingredients sectors. The firm seeks to build resilient, sustainable, and growing businesses that create substantial long-term value. SK Capital aims to utilize its industry, operating, and investment experience to identify opportunities to transform businesses into higher performing organizations with improved strategic positioning, growth, and profitability, as well as lower operating risk. SK Capital currently has approximately $10 billion in assets under management as of December 31, 2024. For more information, please visit www.skcapitalpartners.com.

Forward Looking Statement

This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. All statements that are not statements of historical facts are, or may be deemed to be, forward-looking statements. Such forward-looking statements are based on historical performance and current expectations and projections about bluebird’s future goals, plans and objectives and involve inherent risks, assumptions and uncertainties, including internal or external factors that could delay, divert or change any of them in the next several years, that are difficult to predict, may be beyond bluebird’s control and could cause bluebird’s future goals, plans and objectives to differ materially from those expressed in, or implied by, the statements. No forward-looking statement can be guaranteed. Forward-looking statements in this press release should be evaluated together with the many risks and uncertainties that affect bluebird bio’s business, particularly those identified in the risk factors discussion in bluebird bio’s Annual Report on Form 10-K for the year ended December 31, 2024, as updated by its subsequent Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and other filings with the SEC. These risks and uncertainties include, but are not limited to: the risk that the efficacy and safety results from bluebird’s prior and ongoing clinical trials will not continue or be seen in the commercial context; the risk that there is not sufficient patient demand or payer reimbursement to support continued commercialization of bluebird’s products; the risk of insertional oncogenic or other safety events associated with lentiviral vector, drug product, or myeloablation, including the risk of hematologic malignancy; and the risk that bluebird’s products will not be successfully commercialized. The forward-looking statements included in this document are made only as of the date of this document and except as otherwise required by applicable law, bluebird bio undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, changed circumstances or otherwise.

Contacts: 

 

Bluebird

Courtney O’Leary 

+1 (978) 621-7347

coleary@bluebirdbio.com

 

Carlyle

Brittany Berliner
+1 (212) 813-4839
brittany.berliner@carlyle.com

 

SK Capital

Ben Dillon

+1 (646) 278-1353 
bdillon@skcapitalpartners.com

Categories: News

Tags:

Stout Announces New Investment Partnership With Integrum Seeking to Continue Accelerated Growth Trajectory

Audax Group

Chicago, IL – June 2, 2025 – Stout, a leading global advisory firm, announced today that it has entered into a new strategic partnership with Integrum Holdings LP (“Integrum”), a private investment firm focused on partnering with technology-enabled services companies in the financial and business services sectors. Funds advised by Integrum will invest alongside Stout’s employee shareholders to support the firm’s continued expansion objectives. As part of the transaction, Stout’s management team will remain in place, and existing employee shareholders will retain a meaningful equity stake. The transaction is expected to close in the third quarter of 2025 subject to customary closing conditions.

This new partnership follows a successful and highly collaborative relationship with Audax Private Equity (“Audax”), which first invested in Stout in November 2021 through its Flagship strategy. Over the course of the partnership, Audax provided strategic and financial support that enabled Stout to expand its platform, double headcount, complete ten acquisitions, and accelerate its growth across geographies and service lines.

“We are deeply grateful to Audax for their partnership and support over the past three and a half years,” said Craige Stout, Chief Executive Officer of Stout. “They have been instrumental in helping us further scale our business, and we are proud of what we accomplished together. As we look ahead, we are thrilled to welcome Integrum, whose team brings experience, insight, and common values that align perfectly with our ambitions for the future.”

Jeff Risius, Co-Head of Client Service at Stout, added, “This is a natural next step for Stout. Integrum’s long-term mindset, strategic expertise, and focus on people and culture make them the ideal partner for our next phase of growth.”

Tagar Olson, Founding Partner at Integrum, said, “Stout is a global firm with a reputation for excellence, a strong leadership team, and a clear growth trajectory. We are excited to support their continued expansion and to partner with a firm so deeply committed to client success and employee ownership.”

Bill Allen, Managing Director at Audax and Head of the firm’s Financial Services specialization, commented, “It has been a privilege to partner with the outstanding team at Stout. Over the past several years, we have watched the firm grow significantly in scale, capability, and market presence, all while staying true to its culture of ‘Relentless Excellence®’. We are confident that Stout is well-positioned for continued success. We wish Craige, Jeff, and the entire Stout team the very best as they begin this exciting next chapter with Integrum.”

William Blair & Company acted as financial advisor and Winston & Strawn LLP and Ropes and Gray LLP served as legal counsel to Stout.

Simpson Thacher & Bartlett LLP served as legal counsel to Integrum.

About

About Stout
Stout is a global advisory firm specializing in corporate finance, accounting and transaction advisory, valuation, and financial disputes, claims, and investigations. Stout serves a range of clients, from public corporations to privately held companies in numerous industries. Our clients and their advisors rely on our premier expertise, deep industry knowledge, and unparalleled responsiveness on complex matters. Stout is a trade name for Stout Risius Ross, LLC, Stout Advisors SA, Stout Bluepeak Asia Ltd., Stout GmbH, MB e Associati S.r.l., Stout Park Ltd, and Stout Capital, LLC, a FINRA-registered broker-dealer and SIPC member firm. Learn more at www.stout.com

About Audax Private Equity
Headquartered in Boston, with offices in San Francisco, New York, London and Hong Kong, Audax Private Equity manages three strategies: its Flagship and Origins private equity strategies, seeking control buyouts in the core middle and lower middle markets, respectively, and its Strategic Capital strategy that provides customized equity solutions to PE-backed portfolio companies to help drive continued growth. With approximately $19 billion of assets under management as of March 2025, over 290 employees, and 100-plus investment professionals, Audax has invested in 175 platforms and 1,350 add-on acquisitions since its founding in 1999. Through our disciplined Buy & Build approach, across six core industry verticals, Audax seeks to help portfolio companies execute organic and inorganic growth initiatives with the aim of fueling revenue expansion, optimizing operations, and significantly increasing equity value. For more information, visit www.audaxprivateequity.com or follow us on LinkedIn.

About Integrum
Integrum is an investment firm focused on partnering with technology-enabled services companies in the financial and business services sectors. The firm was founded by a team of proven leaders with a vision to build a different type of investing platform benefiting from their diverse and complementary backgrounds and vast relationship network. Integrum’s approach is to build a concentrated portfolio of high-conviction investments. Integrum aims to accelerate growth through investments in technology and other forms of innovation and by partnering with management teams to enhance access to talent, relationships, and capabilities.
Learn more at www.integrum.us

Categories: News

Tags:

Rezonate Music Rights enters $150 million strategic partnership with Bridgepoint to accelerate growth of premium music producer royalties platform

Bridgepoint
Rezonate Music Rights (“Rezonate”), a leading platform focused on acquiring the royalty rights of top music producers globally, has entered into a strategic partnership with Bridgepoint Credit, one of Europe’s most experienced credit managers.

The partnership will invest to up to $150 million of capital to support a pipeline of high-profile producer catalogue acquisitions, with Bridgepoint acquiring a minority stake in Rezonate’s management company as part of the transaction.

This collaboration marks a significant milestone for Rezonate, unlocking new growth avenues as it accelerates its mission to transform the music royalties sector and empower producers worldwide.

Empowering Music Producers

Rezonate was co-founded by Cam Blackwood, a multi-diamond and platinum-selling songwriter and record producer with over 7 billion streams in his catalogue, and Tom Tyler, who has over 20 years in senior financial roles at HSBC and the London Stock Exchange Group.

The team brings together deep sector experience in music production, valuation, and investment management. Rezonate offers a full suite of services designed to support music creators and investors alike, ensuring producer rights are properly valued, acquired, and developed.

Rezonate has already acquired the rights to the catalogues from leading producers who have produced music for global record-breaking artists such as U2, David Guetta, The Weekend, Dua Lipa, George Ezra, Lewis Capaldi, Snow Patrol, Ed Sheeran, Taylor Swift, Rag’n’Bone Man and Bastille.

Strategic Vision and Industry Leadership

As an innovator in the music royalties space, Rezonate believes in empowering producers not just financially, but through knowledge and mentorship, offering education, industry insights, and networking opportunities to help producers navigate the evolving music business.

The strategic partnership with Bridgepoint is a testament to Rezonate’s leadership and vision, enabling the company to further its mission of supporting music producers by providing transparent pathways to realise the value of their music and create new solutions to support their future ambitions while respecting the long-term value of their work.

Tom Tyler and Cam Blackwood, Co-founders of Rezonate, commented: “This partnership with Bridgepoint is a strong endorsement of Rezonate’s vision and the value we bring to music producers. With Bridgepoint’s support, we gain substantial firepower that will enable us to significantly accelerate our growth plans and continue to set new standards in the industry, ensuring that producers are at the heart of every decision we make. We are excited to bring a fresh and artist-aligned approach to the royalties space, starting with an incredible day-one catalogue that includes some of the most iconic tracks of the past decade.”

Rohit Dhote, Partner and Co-Head of Credit Opportunities at Bridgepoint, commented: “Rezonate offers a rare combination of high-quality income streams, downside-protected entry points and scalable platform dynamics in one of the most exciting corners of the entertainment economy. We’re backing a world-class team with unique access to producers and a clear strategy to create significant value over time. This is a compelling opportunity to build a differentiated royalty platform from the ground up.”

Advisors

Bridgepoint was advised by Latham & Watkins as Legal Advisor and EY as Tax Advisor. Rezonate was advised by Artisan as Financial Advisor and Lewis Silkin as Legal Advisor.

Bridgepoint Group is one of the world’s leading quoted private asset growth investors, specialising in private equity, infrastructure and private credit.

With over $86 billion of assets under management and a strong local presence in Europe, North America and Asia, we combine global scale with local market insight and sector expertise, consistently delivering strong returns through cycles.

Bridgepoint Advisers Limited, a subsidiary of Bridgepoint Group plc, is authorised and regulated by the Financial Conduct Authority.

Categories: News

Tags:

Carlyle partners with Rabo Investments to Invest in SurePay

Rabo Investments

Carlyle Europe Technology Partners (“CETP”), in partnership with Rabo Investments, announced a strategic growth investment in SurePay, a European leader in payment verification software. Following an earlier successful growth trajectory together with Connected Capital and Iris Capital, CETP and Rabo Investments now join forces to further expand SurePay’s suite of payment verification and fraud prevention solutions and geographical expansion.  

 Founded within Rabobank in 2016 and headquartered in the Netherlands, SurePay is a leading provider of payment verification technology solutions to financial institutions and corporates across Europe and the UK. The company reduces fraudulent and misdirected payments through its trusted real-time IBAN-name check, Confirmation-of-Payee (CoP), Verification-of-Payee (VoP), and Fraud Risk Indicator (FRI) products, supporting 200+ banks and 750+ corporate customers.  

 David-Jan Janse, CEO and co-founder of SurePay: 

“We are thrilled to welcome Carlyle as a strategic partner for the next stage of our journey. With Carlyle’s deep experience in financial infrastructure and enterprise software, they are the ideal partner to join Rabo Investments in supporting our ambition to strengthen our leadership across Europe and the UK, and expand into other international markets. This investment is a major milestone for our team and a strong validation of the platform we have built together with top-tier financial institutions and leading corporates around the world.” 

 More about SurePay: Home • SurePay 

Categories: News

Tags:

QUEST SOFTWARE ANNOUNCES NEW $350 MILLION CAPITAL INFUSION TO ACCELERATE AI INNOVATION AND GROWTH

Clearlake

Austin, TX – May 30, 2025 – Quest Software, a global leader in data management, identity security and platform modernization, backed by Clearlake Capital Group, L.P. (together with its affiliates, “Clearlake”), today announced the closing of a refinancing transaction of its outstanding debt with a majority of holders of its existing first lien and second lien term loans. It includes a new capital infusion of $350 million by Quest’s existing lenders, which will help accelerate Quest’s artificial intelligence (AI) innovation and growth initiatives. Participation in the transaction is open to remaining holders.

The $350 million of new term loans mature at the same time as Quest’s existing and refinanced first lien term loans in February 2029. Additionally, Quest extended the maturity of its revolving credit facility to November 2028 and de-levered its balance sheet, strengthening its liquidity position and securing additional financial flexibility to pursue the company’s growth strategy. This investment comes at a pivotal moment for Quest, as organizations across all industries are seeking trusted partners to help navigate the complexities of AI adoption.

“We thank our investors and lenders for their continued support, which we believe signals their confidence in our ability to leverage AI market opportunities,” said Tim Page, CEO of Quest. “We believe AI represents not just a technological shift but a fundamental transformation in how businesses create value. With most of the Fortune 500 companies using Quest Software for data management and identity security, we have an understanding of customer environments and requirements that drives our AI priorities and accelerated investments.”

“We are pleased with the completion of this transaction for Quest and all of its stakeholders including employees, shareholders and lenders,” said Behdad Eghbali, Co-Founder and Managing Partner, and Prashant Mehrotra and Paul Huber, Partners at Clearlake. “We believe this is an especially exciting time for the Company as the market undergoes transformation driven by the adoption of AI, the proliferation of data and the ever-evolving need for cyber resiliency, and we look forward to continuing to partner with the Quest team to accelerate growth and elevate its market position.”

“This transaction will provide enhanced investment and liquidity, allowing us to innovate and expand our suite of identity protection products,” said Mark Logan, CEO of One Identity, a standalone and independent business unit within Quest, specializing in identity and access management (IAM), privileged access management (PAM), and identity governance administration (IGA). “With AI playing an increasingly vital role in the IAM, PAM, and IGA sectors, our focus remains on delivering cutting-edge solutions that help organizations protect and manage identities effectively. We are excited to better serve customers seeking comprehensive identity management solutions and fortify our ability to respond to evolving market demands.”

This investment will support Quest’s expansion of both the embedded AI capability across products in their software portfolio and AI data readiness technology to enable enterprises to fully realize the promise of AI. Key initiatives will begin rolling out immediately, including the new Quest Software Center for Advanced Architecture. As part of this ground-breaking initiative, engineers will develop next-generation solutions for both AI data management and governance and agentic AI to identify and respond to cyber threats at machine speed.

Quest is also investing in building a world-class partner ecosystem specifically for the AI revolution, with specialized solution paths for data partners, identity security specialists, and Microsoft platform integrators working with Active Directory and EntraID environments.

 

About Quest Software

Quest Software creates technology and solutions that build the foundation for enterprise AI. Focused on data management and governance, identity security and platform modernization, Quest helps organizations address their most pressing challenges and make the promise of AI a reality.  Around the globe, more than 130,000 companies including over 90% of the Fortune 500 count on Quest Software.  For more information, visit www.quest.com or follow Quest Software on X (formerly Twitter) and LinkedIn.

 

About One Identity

An independent and standalone business within Quest Software helps organizations get identity and access management (IAM) right. With a unique combination of offerings including a portfolio of identity governance, access management and privileged management, and identity as a service that help organizations reach their full potential, unimpeded by security yet safeguarded against threats. One Identity has proven to be a company unequalled in its commitment to its customers’ long-term IAM success. More than 7,500 customers worldwide depend on One Identity solutions to manage more than 125 million identities, enhancing their agility and efficiency while securing access to their data — wherever it might reside. For more information, visit https://www.oneidentity.com/.

 

About Clearlake

Clearlake Capital Group, L.P. is an investment firm founded in 2006 operating integrated businesses across private equity, credit and other related strategies. With a sector-focused, approach, the firm seeks to partner with experienced management teams by providing patient, long-term capital to dynamic businesses that can benefit from Clearlake’s operational approach, O.P.S.® The firm’s core private equity target sectors are technology, industrials, and consumer. Clearlake currently has over $90 billion of assets under management and its senior investment principals have led or co-led over 400 investments, and has deployed over $57 billion in liquid and illiquid credit investments globally. The firm is headquartered in Santa Monica, CA with affiliates in Dallas, TX, London, UK, Dublin, Ireland, Luxembourg, Abu Dhabi, UAE, and Singapore. More information is available at www.clearlake.com.

 

Media Contacts:
For Quest:

Slava Balykov

slava.balykov@quest.com

 

For Clearlake:

Jennifer Hurson

Jhurson@lambert.com

Categories: News

Tags:

CDTI Innovation’s SICC Innvierte Invests in Next Technology Ventures II to Drive Innovative Solutions for Critical Energy Transition Challenges

Axon

With this investment, CDTI Innovation reaffirms its commitment to promoting projects that empower national companies to lead international markets, create high-quality employment, and enhance their competitiveness through advanced technology.

CDTI Innovation, through its Innvierte initiative, has invested 15 million euros in Next Technology Ventures II (NTV II), managed by Axon Partners Group. This investment aims to promote the development of high technology (‘Deeptech’) in SMEs within the climate sector (generation and smart grids, smart buildings and distributed energy, transport and mobility, industry, and circular economy), primarily targeting early-stage companies.

Next Technology Ventures II:

Driving Technological Innovation in Early-Stage Climate Solutions With a total size exceeding 60 million euros, NTV II began building its portfolio in 2023. Targeting between twenty and thirty investee companies, the fund has already made its first twelve investments in companies developing solutions to global challenges such as industrial decarbonisation (Build to Zero), green hydrogen production and carbon capture (Parallel Carbon), renewable energies and grid flexibility (Hepta, Phelas, or Novatron), and the circular economy (Nextmol).

Additionally, these companies are advancing enabling technologies based on IoT (Energiot or Wsense), new materials (Jolt), and even Quantum Computing applied to energy (Quilimanjaro).

The fund is managed by Axon Partners Group, which, since 2019, has maintained a dedicated investment strategy focused exclusively on the climate technology and energy transition ecosystem. While global in scope, Axon’s strategy prioritises Spain and Southern Europe.

Innvierte:

Promoting Business Innovation Through Venture Capital, Innvierte is a programme that fosters business innovation by supporting venture capital investments in technology-driven or innovative companies. Implemented through the closed-end collective investment entity Innvierte Economía Sostenible SICC S.M.E., S.A., this initiative operates under the supervision of the Spanish National Securities Market Commission (CNMV), with CDTI Innovation as its sole shareholder.

To date, CDTI Innovation has committed 2,183 million euros in 57 investment vehicles that have invested in over 602 companies. It has directly committed 632 million euros to 188 companies through its co-investment line.

Innvierte is part of the Spanish Science, Technology, and Innovation Strategy 2021-2027, approved by the Council of Ministers in September 2020. This strategy outlines the objectives, reforms, and measures to be implemented across the R&D&I sector to drive its growth and impact, forming a key pillar in the government’s R&D&I policy for the coming years.

Categories: News

Tags:

Altor divests all shares in XXL

27 May 2025. Altor Fund IV (“Altor”) has today accepted the mandatory offer from Frasers Group Plc for XXL ASA (“XXL” or the “Company”) and thereby sold 23,491,568 A shares and 17,051,037 B shares in XXL ASA, representing all its shares and votes in the Company, at a price of NOK 10 per share. Following these transactions, Altor will own no shares in XXL. Altor has supported XXL since they partnered in 2019.

“Given the current situation and the increasing short-term challenges, Altor has decided to accept Frasers Group’s offer, in line with the Board’s new recommendation. As we now hand over to Frasers Group, we believe XXL will benefit from their industry experience and benefit from being part of a larger group” said Øistein Widding, Partner and Head of Norway.

Andreas Källström Säfweräng, Partner and Head of the Consumer Sector continued: “XXL’s management team and dedicated employees are working hard every day to build a stronger company, and Altor believes they’ll succeed in getting back to profitable growth. That said, there are still real challenges ahead short-term. We see this as the right time for Frasers Group to guide the next chapter.”

About Altor

Since inception, the family of Altor funds has raised more than EUR 12 billion in total commitments. The funds have invested in just south of 100 companies. The investments have been made in medium-sized predominantly Nordic and DACH companies with the aim to create value through growth initiatives and operational improvements. Among current and past investments are Helly Hansen, Meltwater, CCM Hockey, and Toteme.

Press contact

Karin Åström

Head of Communications

karin.astrom@altor.com

+46 707 64 86 59

Categories: News

Tags: